Systemic Adipokines, Hepatokines and Interleukin-6 in HCV-monoinfected and HCV/HIV Coinfected Patients Treated With Direct Antiviral Agents (DAAs)

Clinics and Research in Hepatology and Gastroenterology - France
doi 10.1016/j.clinre.2018.02.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

BMC Infectious Diseases
Infectious Diseases
2020English

Benefit of Direct-Acting Antiviral Therapy for Hepatitis C Virus (HCV) in Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

HIV Clinical Trials
2009English

Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Acquired Hemophilia a Resolution in an HCV/HIV Coinfected Patient With Cure of Hepatitis C by Direct Antiviral Agents

Hepatology
MedicineHepatology
2018English

Evolution of Pretreatment Assessment and Direct Acting Antiviral Regimens in Accordance With Upgrading Guidelines: A Retrospective Study in HIV/HCV Coinfected Patients

Medical Sciences
2018English

Patient-Reported Symptoms During Direct-Acting Antiviral Treatment: A Real-Life Study in HIV-HCV Coinfected Patients (ANRS CO13 HEPAVIH)

Journal of Hepatology
Hepatology
2020English

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents

Frontiers in Medicine
Medicine
2019English

Soluble Adhesion Molecules in Patients Coinfected With HIV and HCV: A Predictor of Outcome

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy